Moderna shares plunge after cancer vaccine data leaks — despite positive results
Summary
Moderna shares dropped significantly following the early leak of experimental cancer vaccine data. Despite the subsequent release of full results that aligned with positive Wall Street expectations, the stock price continued to decline.
Moderna released full data on its closely watched cancer vaccine developed with Merck.
Source: Read the full story at US Top News and Analysis
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.